1-tert-Butyl 3-ethyl 4-aminopiperidine-1,3-dicarboxylate, 95.0%, 250mg

Diisopropylamine, min 99.5%, for synthesis, 1L, glass packaging

(S)-1-Benzyl-3-ethylpiperazine-2,5-dione, 95.0%, 100g

Pyrrolidine, 2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]diphenylmethyl]-, (2R)-, 98%, 1g

2-Amino-5-bromo-6-chloropyrazine, 95.0%, 10g

(4-Hydroxy-phenyl)-piperazin-1-yl-methanone, 2.5g

Ethyl 6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine-2-carboxylate, 95+%, 250mg

5-(Imidazo[1,2-a]pyridin-6-yl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, 95.0%, 5mg

(1R,2R)-cyclohex-4-ene-1,2-dicarboxylic acid, 95+%, 1g

3,3,5,5-Tetramethylcyclohexanone, 95.0%, 5g

Falecalcitriol, 95.09%, 5mg

3-Methyl-4-nonanone, 97.0%, 1g

3-[[(Benzylthio)carbonothioyl]thio]propionic Acid>98.0%(T)1g